Huddle with Dr. Justin Johnson, PhD and Dr. G. Thomas Budd, MD
Dr. Justin Johnson, PhD and Dr. G. Thomas Budd, MD will provide us with the status and progress of the Phase I trial of an alpha-lactalbumin vaccine in patients with operable triple-negative breast.
G. Thomas BuddMedical Doctor, Hematology and Medical Oncology, Cleveland Clinic
George Thomas Budd, MD, is a staff physician in the Taussig Cancer Center at Cleveland Clinic. His clinical interests include breast cancer, sarcomas and experimental therapeutics. His research interests are focused on experimental therapies, breast cancer and sarcomas.
Board-certified in internal medicine with a subspecialty in medical oncology, Dr. Budd has authored more than 175 articles, book chapters and textbooks. He is a reviewer for numerous peer-reviewed publications including Journal of Clinical Oncology, Cancer and Clinical Cancer Research.
In addition, Dr. Budd is a fellow of the American College of Physicians and a member of the Society of Clinical Oncology and American Association for Cancer Research.
Dr. Budd received his medical degree from the University of Kansas Medical School. He completed his internship, residency, and fellowship in medical oncology at Cleveland Clinic.
Justin Johnson Program Manager, Vincent Tuohy Laboratory, Cleveland Clinic Lerner Research InstituteJustin JohnsonProgram Manager, Vincent Tuohy Laboratory, Cleveland Clinic Lerner Research Institute